Mary Kerr CEO NeRRe Therapeutics guest speaker at a recent Labiotech meeting in London

Home / Company News / Mary Kerr CEO NeRRe Therapeutics guest speaker at a recent Labiotech meeting in London

Mary Kerr CEO NeRRe Therapeutics guest speaker at a recent Labiotech meeting in London2017-12-042018-09-14https://www.nerretherapeutics.com/wp-content/uploads/2018/09/logo.pngNeRRe Therapeuticshttps://www.nerretherapeutics.com/wp-content/uploads/2018/09/logo.png200px200px

NeRRe Therapeutics is a UK based clinical-stage company developing a unique portfolio of neurokinin (NK) receptor antagonists for the treatment of common debilitating conditions caused by neuronal hypersensitivity.

Useful Links

Contact Us
About Us
Privacy Policy
Cookie Notice
Terms & Conditions
Clinical Trials Privacy Notice

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

KaNDy Therapeutics launched to advance a breakthrough treatment in Women’s HealthCompany News

Say Hello to the Top 14 Female Entrepreneurs in European BiotechCompany News

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Enable or Disable Cookies Enabled Disabled

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Enable or Disable Cookies Enabled Disabled

Cookie Policy

More information about our Cookie Policy